PCVX - Vaxcyte, Inc.

Insider Sale by Cowan Elvia (SVP, Finance, CAO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Cowan Elvia, serving as SVP, Finance, CAO at Vaxcyte, Inc. (PCVX), sold 2,500 shares at $58.59 per share, for a total transaction value of $146,482.00. Following this transaction, Cowan Elvia now holds 30,867 shares of PCVX.

This sale represents a 7.00% decrease in Cowan Elvia's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, March 11, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 11, 2026, meaning the disclosure happened on the same day as the trade.

Vaxcyte, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Cowan Elvia

SVP, Finance, CAO

Elvia Cowan is a Senior Vice President of Finance at Vaxcyte, Inc. (NASDAQ: PCVX), a biotechnology company based in San Carlos, California.[[1]](https://www.webull.com.my/news-detail/14126782982865920)[[5]](https://www.zoominfo.com/p/Elvia-Cowan/2977374587) In this role, she oversees key financial operations and has been actively involved in insider transactions, including a significant sale of 11,623 shares on December 23, 2025, at an average price of $47.94 per share, valued at approximately $557,000, which reduced her holdings by 84% and was the largest individual insider sale of Vaxcyte stock in the prior twelve months.[[1]](https://www.webull.com.my/news-detail/14126782982865920)[[3]](https://www.ainvest.com/news/vaxcyte-svp-cowan-elvia-sells-4907-6716-shares-47-9-share-47-94-share-2512/)[[4]](https://www.moomoo.com/news/post/63505683/senior-vice-president-of-finance-elvia-cowan-sold-a-bunch) Prior to joining Vaxcyte, Cowan served as Vice President, Controller at 23andMe, demonstrating her extensive experience in financial leadership within the biotech and consumer genetics sectors.[[5]](https://www.zoominfo.com/p/Elvia-Cowan/2977374587) Her career highlights include multiple stock transactions at Vaxcyte, such as sales in 2024 totaling over $1.2 million, underscoring her ongoing involvement as a key executive.[[6]](https://www.secform4.com/insider-trading/1960048.htm) No specific education details are available from the sources.

View full insider profile →

Trade Price

$58.59

Quantity

2,500

Total Value

$146,482.00

Shares Owned

30,867

Trade Date

Wednesday, March 11, 2026

4 days ago

SEC Filing Date

Wednesday, March 11, 2026

HEALTHCAREBIOTECHNOLOGY

About Vaxcyte, Inc.

Company Overview

No company information available
View news mentioning PCVX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4696452

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime